WCTC 2022 - World Congress on Thyroid Cancer
Apr 09 - Oct 01, 2022 | BostonMAUS
LARVOL is not affiliated with World Congress on Thyroid Cancer and all trademarks, logos, and brand names are property of their respective owners
Condition
Product
MOA
Trial Name/ID
Showing 1 titles linked to Trials
Retevmo® (selpercatinib) A precision-based therapy for certain RET-driven cancers-Focus on Advanced or Metastatic Thyroid Cancer